Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are anticipating strong results driven by the strong demand of Lilly's blockbuster medications, particularly its insulin portfolio. Howe